Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Recalibrates Office Of Generic Drugs
As Part Of Wider Structural Changes To CDER
Jan 11 2021
•
By
David Wallace
The FDA is reorganizing the Office of Generic Drugs • Source: Shutterstock
(Sarah Silbiger/Getty Images)
More from Regulation
More from Policy & Regulation